BMT/Oncology Infusion Registered Nurse

Organization
Fred Hutchinson Cancer Research Center & Seattle Cancer Care Alliance
Job Location
Seattle, WA
Job Description

This position provides direct patient care and is critical in the management of our patients being treated with chemotherapy/biologic therapy agents, blood products, immunotherapy/CAR T-Cell and Stem Cell infusion, IV fluids and other medications.

This is a .80 FTE position (32 hours a week).

The essential responsibilities are as follows:
- Perform nursing assessment prior to each infusion, review relevant lab results, pain assessment and other symptoms.
- Assure the safety of patients by following all procedures related to verification of orders and products when administering chemotherapy and blood products.
- Demonstrate an awareness of the potentially hazardous nature of many of the agents administered and uses correct precautions when handling them.
- Follow all procedures regarding safe disposal of any materials used in the administration of chemotherapy or other toxic agents and blood products.
- Communicate patient symptoms including complaints presented upon arrival to the case manager or team nurse.
- Request consultation from social work, dietician or pastoral care staff when patient's situation indicates.
- Document all nursing care activities accurately and in a timely fashion.
- Demonstrate knowledge and understanding of patient privacy rights.

- Washington State RN license required
- BLS
- 2 years of experience in infusion nursing experience required
- Experience administering chemotherapy and infusion
- BSN preferred
- OCN certification preferred
- Outpatient nursing experience preferred

We are a VEVRAA Federal Contractor

If interested, please apply online at http://track.tmpservice.com/ApplyClick.aspx?id=2252991-2647-8521

Students whose classmates are interested in science are more likely to think about a career in science, technology, engineering, and mathematics, a new study says.

CNBC reports that the genetic counseling field is expected to grow as personalized medicine becomes more common.

Gladys Kong writes at Fortune that her STEM background has helped her as a CEO.

Social scientists report that the image of the 'lone scientist' might be deterring US students from STEM careers.